PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1574996
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1574996
Hospital-Acquired Disease Testing Market, By Infection Type, By Testing Technology, By Test Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Hospital-Acquired Disease Testing Market size was valued at USD 12,290.32 Million in 2023, expanding at a CAGR of 15.90% from 2024 to 2032.
The Hospital-Acquired Disease Testing Market focuses on diagnostic tests for infections acquired in healthcare settings, impacting patient safety and hospital resources. Rising incidences of hospital-acquired infections (HAIs), such as MRSA and C. difficile, emphasize the need for effective testing solutions; for instance, HAIs affect approximately 1 in 31 hospital patients in the U.S., highlighting significant challenges for healthcare providers. Increasing awareness about infection control and advancements in molecular diagnostics are key drivers for market growth. However, factors such as high testing costs and stringent regulatory frameworks may hinder adoption. Opportunities abound in developing innovative rapid testing methods and expanding testing capabilities, particularly in emerging markets where healthcare infrastructure is improving. As hospitals prioritize patient safety and regulatory compliance, investments in advanced testing technologies are expected to rise, fostering a more proactive approach to infection management.
Hospital-Acquired Disease Testing Market- Market Dynamics
Rising Incidences of Hospital-Acquired Infections Propel Demand for Advanced Testing Solutions in the Hospital-Acquired Disease Testing Market
The rising incidence of hospital-acquired infections (HAIs) has significantly increased the demand for advanced testing solutions in healthcare settings. These infections, such as urinary tract infections (UTIs), surgical site infections, and bloodstream infections, pose severe risks to patient health and have led to extended hospital stays and higher mortality rates. According to the Centers for Disease Control and Prevention (CDC), HAIs affect millions of patients annually, prompting the development of more precise and rapid diagnostic tools. Governments and healthcare organizations worldwide have launched initiatives to combat HAIs. For instance, the World Health Organization (WHO) promotes stringent hygiene protocols, while countries like the UK have introduced financial penalties for hospitals with high infection rates. The increasing focus on real-time, accurate testing methods, such as Polymerase Chain Reaction (PCR) and rapid diagnostic tests, is expected to drive further advancements in hospital-acquired disease testing.
Hospital-Acquired Disease Testing Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.90% over the forecast period (2024-2032)
Based on Infection type segmentation, Urinary Tract Infections. was predicted to show maximum market share in the year 2023
Based on Testing Technology segmentation, PCR (Polymerase Chain Reaction). was the leading type in 2023
Based on Test Type segmentation, Molecular Diagnostics was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
Hospital-Acquired Disease Testing Market- Segmentation Analysis:
The Global Hospital-Acquired Disease Testing Market is segmented on the basis of Infection type, Testing Technology, Test Type, End-User, and Region.
The market is divided into four categories based on Infection type: Urinary Tract Infections, Surgical Site Infections, Respiratory Infections, and Bloodstream Infections. Urinary Tract Infections (UTIs) rank highest due to their prevalence in healthcare settings, followed by Surgical Site Infections, which are critical post-operative concerns. Respiratory Infections come next, with Bloodstream Infections being the least common yet severe.
The market is divided into four categories based on Testing Technology: PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), Microbial Culture, and Rapid Diagnostics. PCR (Polymerase Chain Reaction) leads due to its accuracy and speed, followed by ELISA (Enzyme-Linked Immunosorbent Assay), which is widely used for antibody detection. Microbial Culture ranks next, with Rapid Diagnostics being the least prioritized.
Hospital-Acquired Disease Testing Market- Geographical Insights
The Hospital-Acquired Disease Testing Market shows significant regional variation, with North America leading due to its advanced healthcare infrastructure and high incidence of hospital-acquired infections (HAIs), which affect approximately 1 in 31 hospitalized patients. Europe follows closely, driven by stringent regulations and increased awareness of infection control measures. In Asia-Pacific, rapid urbanization and the expansion of healthcare facilities contribute to market growth, particularly in countries like India and China, where hospital-acquired infections are becoming a pressing concern. Initiatives such as the World Health Organization's Global Infection Prevention and Control Network aim to enhance surveillance and management of HAIs in low-resource settings, further stimulating demand. Meanwhile, Latin America and the Middle East are witnessing growth as hospitals upgrade their testing capabilities to combat rising infection rates. These regions are increasingly adopting advanced diagnostic technologies, showcasing a global trend towards improving patient safety and quality of care in healthcare settings.
Hospital-Acquired Disease Testing Market- Competitive Landscape:
The Hospital-Acquired Disease Testing Market is characterized by a competitive landscape with key players such as Abbott Laboratories, Roche Diagnostics, and bioMerieux leading in North America, which is the dominant region due to its extensive healthcare systems and significant investment in diagnostic technologies. Europe follows, where companies like Siemens Healthineers and Thermo Fisher Scientific are strengthening their positions through strategic partnerships and innovations in infection detection methods. In the Asia-Pacific region, local players are emerging, driven by the increasing prevalence of hospital-acquired infections, with countries like India and China ramping up their testing capabilities to meet rising demand. Notably, the Indian government has launched initiatives to enhance infection control practices in hospitals, further boosting market growth. Meanwhile, in Latin America and the Middle East, companies are focusing on expanding their distribution networks and increasing awareness about HAIs, contributing to market dynamics. Overall, the competitive landscape is marked by innovation and strategic collaborations aimed at improving patient outcomes across diverse healthcare settings.
Recent Developments:
In November 2021, PINC AI(TM) Applied Sciences and Molnlycke Health Care AB launched a clinical trial to evaluate the effectiveness of Molnlycke's Mepilex Border Flex dressings in reducing hospital-acquired pressure injuries (HAPIs) in acute care settings.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Becton, Dickinson, and Company
- bioMerieux S.A.
- Bio-Rad Laboratories, Inc.
- Cardinal Health, Inc.
- Cepheid Inc. (A Danaher Company)
- Danaher Corporation
- F. Hoffmann-La Roche AG
- GenMark Diagnostics, Inc.
- Hologic, Inc.
- Luminex Corporation
- Merck KGaA
- Qiagen N.V.
- QuidelOrtho Corporation
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Others
GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY INFECTION TYPE- MARKET ANALYSIS, 2019 - 2032
- Urinary Tract Infections
- Surgical Site Infections
- Respiratory Infections
- Bloodstream Infections
GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY TESTING TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- PCR (Polymerase Chain Reaction)
- ELISA (Enzyme-Linked Immunosorbent Assay)
- Microbial Culture
- Rapid Diagnostics
GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Molecular Diagnostics
- Immunoassays
- Conventional Culture Tests
GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Laboratories
- Ambulatory Surgery Centers
- Academic & Research Institutes
GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Hospital-Acquired Disease Testing Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Hospital-Acquired Disease Testing Market Snippet by Infection type
- 2.1.2. Hospital-Acquired Disease Testing Market Snippet by Testing Technology
- 2.1.3. Hospital-Acquired Disease Testing Market Snippet by Test Type
- 2.1.4. Hospital-Acquired Disease Testing Market Snippet by End-User
- 2.1.5. Hospital-Acquired Disease Testing Market Snippet by Country
- 2.1.6. Hospital-Acquired Disease Testing Market Snippet by Region
- 2.2. Competitive Insights
3. Hospital-Acquired Disease Testing Key Market Trends
- 3.1. Hospital-Acquired Disease Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Hospital-Acquired Disease Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Hospital-Acquired Disease Testing Market Opportunities
- 3.4. Hospital-Acquired Disease Testing Market Future Trends
4. Hospital-Acquired Disease Testing Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Hospital-Acquired Disease Testing Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Hospital-Acquired Disease Testing Market Landscape
- 6.1. Hospital-Acquired Disease Testing Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Hospital-Acquired Disease Testing Market - By Infection type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Infection type, 2023 & 2032 (%)
- 7.1.2. Urinary Tract Infections
- 7.1.3. Surgical Site Infections
- 7.1.4. Respiratory Infections
- 7.1.5. Bloodstream Infections
8. Hospital-Acquired Disease Testing Market - By Testing Technology
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Testing Technology, 2023 & 2032 (%)
- 8.1.2. PCR (Polymerase Chain Reaction)
- 8.1.3. ELISA (Enzyme-Linked Immunosorbent Assay)
- 8.1.4. Microbial Culture
- 8.1.5. Rapid Diagnostics
9. Hospital-Acquired Disease Testing Market - By Test Type
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
- 9.1.2. Molecular Diagnostics
- 9.1.3. Immunoassays
- 9.1.4. Conventional Culture Tests
10. Hospital-Acquired Disease Testing Market - By End-User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 10.1.2. Hospitals
- 10.1.3. Diagnostic Laboratories
- 10.1.4. Ambulatory Surgery Centers
- 10.1.5. Academic & Research Institutes
11. Hospital-Acquired Disease Testing Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Hospital-Acquired Disease Testing Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Hospital-Acquired Disease Testing Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3. Italy Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.3.9.4. Italy Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.3.9.5. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3. United Kingdom Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.3.10.4. United Kingdom Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.3.10.5. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. France
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3. France Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.3.11.4. France Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.3.11.5. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
- 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.2. Russia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.3.12.3. Russia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.3.12.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
- 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.2. Netherlands Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.3.13.3. Netherlands Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.3.13.4. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.2. Sweden Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
- 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.2. Poland Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.3.15.3. Poland Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.3.15.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3. Rest of the Europe Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.3.16.4. Rest of the Europe Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.3.16.5. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Hospital-Acquired Disease Testing Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. India
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3. India Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.4.8.4. India Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.4.8.5. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. China
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3. China Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.4.9.4. China Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.4.9.5. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3. Thailand Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.4.13.4. Thailand Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.4.13.5. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3. Indonesia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.4.14.4. Indonesia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.4.14.5. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Hospital-Acquired Disease Testing Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Hospital-Acquired Disease Testing Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Infection type, 2019 - 2032 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Testing Technology, 2019 - 2032 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Hospital-Acquired Disease Testing Industry
- 12.1. Competitive Dashboard
- 12.2. Company Profiles
- 12.2.1. Abbott Laboratories
- 12.2.2. Becton, Dickinson and Company
- 12.2.3. bioMerieux S.A.
- 12.2.4. Bio-Rad Laboratories, Inc.
- 12.2.5. Cardinal Health, Inc.
- 12.2.6. Cepheid Inc. (A Danaher Company)
- 12.2.7. Danaher Corporation
- 12.2.8. F. Hoffmann-La Roche AG
- 12.2.9. GenMark Diagnostics, Inc.
- 12.2.10. Hologic, Inc.
- 12.2.11. Luminex Corporation
- 12.2.12. Merck KGaA
- 12.2.13. Qiagen N.V.
- 12.2.14. QuidelOrtho Corporation
- 12.2.15. Siemens Healthineers AG
- 12.2.16. Thermo Fisher Scientific Inc.
- 12.2.17. Others
13. 360 Degree Analyst View
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
